Nishiwaki Hiroki, Hasegawa Takeshi, Ikenoue Tatsuyoshi, Tominaga Naoto, Yazawa Masahiko, Kawarazaki Hiroo, Shibagaki Yugo, Yamamoto Yosuke, Fukuma Shingo, Yamazaki Shin, Fukuhara Shunichi
1 Center for Innovative Research for Community and Clinical Excellence, Fukushima Medical University, Fukushima - Japan.
2 Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto - Japan.
J Vasc Access. 2018 Jan;19(1):69-75. doi: 10.5301/jva.5000798.
Although a few dialysis facilities conduct a complete blood cell count for some patients at post-dialysis, including hemoglobin, clinical findings supporting the interpretation of results are scarce. The aim of this study was to investigate the association between post-dialysis hemoglobin level and vascular access failure with clinical data.
Study design: Case crossover design.
Japanese dialysis facilities, which routinely take post-dialysis blood samples, including complete blood cell counts at least once a month.
Hemodialysis patients who experienced vascular access failure in January 2010 until December 2014.
Post-dialysis hemoglobin level.
Vascular access failure treated with endovascular treatment or operation.
Self-matched odds ratios and 95% confidence intervals were estimated by comparing post-dialysis hemoglobin just before events ("case") with levels at 6 and 12 months before events ("control") using conditional logistic regression, and presented with restricted cubic spline.
Two hundred and thirty hemodialysis patients with vascular access failure were identified. Mean post-dialysis hemoglobin level before the failure was 11.8 g/dL (standard deviation 1.7). The spline curve showed that higher post-dialysis hemoglobin levels above 11.8 g/dL had a greater odds ratio for vascular access failure. Post-dialysis hemoglobin levels and odds ratios (95% confidence interval) for vascular access failure relative to the reference value (Hb 11.8 g/dL) were Hb 12.0 g/dL, 1.1 (1.0-1.1); Hb 14.0 g/dL, 1.4 (1.0-2.0); and Hb 16.0 g/dL, 2.1 (1.1-4.3).
A higher post-dialysis hemoglobin level was associated with vascular access failure. Higher post-dialysis Hb could be a factor that triggers vascular access failure.
尽管一些透析机构会在透析后为部分患者进行全血细胞计数,包括血红蛋白检测,但支持对结果进行解读的临床发现却很稀少。本研究的目的是通过临床数据调查透析后血红蛋白水平与血管通路失败之间的关联。
研究设计:病例交叉设计。
日本透析机构,这些机构常规采集透析后血样,包括每月至少一次的全血细胞计数。
2010年1月至2014年12月期间经历血管通路失败的血液透析患者。
透析后血红蛋白水平。
接受血管内治疗或手术治疗的血管通路失败。
通过使用条件逻辑回归比较事件发生前(“病例”)的透析后血红蛋白与事件发生前6个月和12个月的水平(“对照”),估计自我匹配的优势比和95%置信区间,并以受限立方样条呈现。
确定了230例发生血管通路失败的血液透析患者。失败前透析后血红蛋白水平的平均值为11.8 g/dL(标准差1.7)。样条曲线显示,透析后血红蛋白水平高于11.8 g/dL时,血管通路失败的优势比更大。相对于参考值(血红蛋白11.8 g/dL),透析后血红蛋白水平与血管通路失败的优势比(95%置信区间)分别为:血红蛋白12.0 g/dL,1.1(1.0 - 1.1);血红蛋白14.0 g/dL,1.4(1.0 - 2.0);血红蛋白16.0 g/dL,2.1(1.1 - 4.3)。
透析后血红蛋白水平较高与血管通路失败相关。较高的透析后血红蛋白水平可能是引发血管通路失败的一个因素。